Clinical Trial Update: A Phase II Study of a Continuous Hepatic Arterial Infusion Combination Therapy With OPC-18 and 5-FU in Patients With Highly Advanced Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase II study evaluating continuous hepatic arterial infusion of OPC-18 plus 5-FU for highly advanced hepatocellular carcinoma; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• 5-FU (5-fluorouracil)
• OPC-18

Snippet

Sponsor: Otsuka Pharmaceutical Co., Ltd. | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED